Device Trial Radar · NCT02844920
Evaluation of Uterine Patency Following Sonography-guided Transcervical Ablation of Fibroids
Last checked: Nov 20, 2026Latest source record: Sep 20, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
37
Actual
Start
Jul 20, 2017
Primary completion
Aug 27, 2018
Study completion Aug 27, 2018
Sponsor
- Lead sponsor
- GynesonicsNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jul 26, 2016
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is designed to observe the presence or absence of intrauterine adhesions at 6 weeks after treatment with the Sonata® System through hysteroscopic evaluation by third party readers.
Conditions
- Uterine Fibroids
- Adhesions
Interventions
Intrauterine ultrasound guided radio-frequency ablationDevice
Radiofrequency ablation for the treatment of uterine fibroids
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Absence of Newly Formed Intrauterine Adhesions Following RF Ablation of FibroidsTime frame: 6 weeks
Locations
6 sites in 4 countries. Site status is shown where the registry gives one.
Klinikum Mannheim Universitäts- Frauenklinik Medizinische Fakultät Mannheim der Universität Heidelberg
Mannheim, Germany
Klinikum Oldenburg
Oldenburg, Germany
Universitätsklinikum Tübingen
Tübingen, Germany
3 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.